Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey

• Published in: International journal of antimicrobial agents Vol. 22; no. 1; pp. 70 - 72
• Main Authors: Esel, Duygu, Doganay, Mehmet, Sumerkan, Bulent
• Format: Journal Article
• Language: English
• Published: London Elsevier B.V 01.07.2003; Amsterdam Elsevier; New York, NY
• Subjects: Anthrax - drug therapy; Anthrax - microbiology; Anti-Bacterial Agents - pharmacology; Antibacterial agents; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antimicrobial susceptibility; Bacillus anthracis; Bacillus anthracis - drug effects; Bacillus anthracis - isolation & purification; Biological and medical sciences; Ciprofloxacin - pharmacology; Doxycycline - pharmacology; Drug Resistance, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Levofloxacin; Medical sciences; Microbial Sensitivity Tests; Ofloxacin - pharmacology; Penicillin G - pharmacology; Penicillins - pharmacology; Pharmacology. Drug treatments; Quinolones; Turkey; Asia; Turkey; Bacillus anthracis; Antimicrobial susceptibility; Quinolones; Human; Bacillaceae; In vitro; Biological activity; Antibiotic; Sensitivity resistance; Bacillales; Bacteria; Antibacterial agent; Clinical isolate; Quinolone derivatives
• ISSN: 0924-8579; 1872-7913
• DOI: 10.1016/S0924-8579(03)00097-9

Forty clinical isolates of Bacillus anthracis were studied. The MIC 90 values of penicillin G, doxycycline, ciprofloxacin, gatifloxacin, and levofloxacin were 0.016, 0.03, 0.06, 0.06 and 0.12 mg/l, respectively. Susceptibilities suggest that the quinolones may also be considered as an alternative therapy for anthrax.